|
1
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer Cell. 1:49–52. 2002. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar
|
|
3
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group. Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar
|
|
4
|
Khuri FR, Herbst RS and Fossella FV:
Emerging therapies in non-small-cell lung cancer. Ann Oncol.
12:739–744. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Soria JC, Jang SJ, Khuri FR, Hassan K, Liu
D, Hong WK and Mao L: Overexpression of cyclin B1 in early-stage
non-small cell lung cancer and its clinical implication. Cancer
Res. 60:4000–4004. 2000.PubMed/NCBI
|
|
6
|
Vora SA, Daly BD, Blaszkowsky L, McGrath
JJ, Bankoff M, Supran S and Dipetrillo TA: High dose radiation
therapy and chemotherapy as induction treatment for stage III
nonsmall cell lung carcinoma. Cancer. 89:1946–1952. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng KW, Facteau S, Wegman T, O’Kane D and
Russell SJ: Non-invasive in vivo monitoring of trackable viruses
expressing soluble marker peptides. Nat Med. 8:527–531. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhong H, Han B, Tourkova IL, Lokshin A,
Rosenbloom A, Shurin MR and Shurin GV: Low-dose paclitaxel prior to
intratumoral dendritic cell vaccine modulates intratumoral cytokine
network and lung cancer growth. Clin Cancer Res. 13:5455–5462.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Erlenhoefer C, Wurzer WJ, Löffler S,
Schneider-Schaulies S, ter Meulen V and Schneider-Schaulies J:
CD150 (SLAM) is a receptor for measles virus but is not involved in
viral contact-mediated proliferation inhibition. J Virol.
75:4499–4505. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tatsuo H, Ono N, Tanaka K and Yanagi Y:
SLAM (CDw150) is a cellular receptor for measles virus. Nature.
406:893–897. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsu EC, Iorio C, Sarangi F, Khine AA and
Richardson CD: CDw150 (SLAM) is a receptor for a lymphotropic
strain of measles virus and may account for the immunosuppressive
properties of this virus. Virology. 279:9–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dörig RE, Marcil A, Chopra A and
Richardson CD: The human CD46 molecule is a receptor for measles
virus (Edmonston strain). Cell. 75:295–305. 1993.PubMed/NCBI
|
|
13
|
Naniche D, Varior-Krishnan G, Cervoni F,
Wild TF, Rossi B, Rabourdin-Combe C and Gerlier D: Human membrane
cofactor protein (CD46) acts as a cellular receptor for measles
virus. J Virol. 67:6025–6032. 1993.PubMed/NCBI
|
|
14
|
Bjørge L, Hakulinen J, Wahlström T, Matre
R and Meri S: Complement-regulatory proteins in ovarian
malignancies. Int J Cancer. 70:14–25. 1997.
|
|
15
|
Grote D, Russell SJ, Cornu TI, Cattaneo R,
Vile R, Poland GA and Fielding AK: Live attenuated measles virus
induces regression of human lymphoma xenografts in immunodeficient
mice. Blood. 97:3746–3754. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grote D, Cattaneo R and Fielding AK:
Neutrophils contribute to the measles virus-induced antitumor
effect: enhancement by granulocyte macrophage colony-stimulating
factor expression. Cancer Res. 63:6463–6468. 2003.
|
|
17
|
Peng KW, Ahmann GJ, Pham L, Greipp PR,
Cattaneo R and Russell SJ: Systemic therapy of myeloma xenografts
by an attenuated measles virus. Blood. 98:2002–2007. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dingli D, Peng KW, Harvey ME, Greipp PR,
O’Connor MK, Cattaneo R, Morris JC and Russell SJ: Image-guided
radiovirotherapy for multiple myeloma using a recombinant measles
virus expressing the thyroidal sodium iodide symporter. Blood.
103:1641–1646. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Phuong LK, Allen C, Peng KW, Giannini C,
Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ and Galanis
EC: Use of a vaccine strain of measles virus genetically engineered
to produce carcinoembryonic antigen as a novel therapeutic agent
against glioblastoma multiforme. Cancer Res. 63:2462–2469.
2003.
|
|
20
|
Peng KW, TenEyck CJ, Galanis E, Kalli KR,
Hartmann LC and Russell SJ: Intraperitoneal therapy of ovarian
cancer using an engineered measles virus. Cancer Res. 62:4656–4662.
2002.PubMed/NCBI
|
|
21
|
Pumphrey CY, Theus AM, Li S, Parrish RS
and Sanderson RD: Neoglycans, carbodiimide-modified
glycosaminoglycans: a new class of anticancer agents that inhibit
cancer cell proliferation and induce apoptosis. Cancer Res.
62:3722–3728. 2002.PubMed/NCBI
|
|
22
|
Wei YQ, Zhao X, Kariya Y, Fukata H,
Teshigawara K and Uchida A: Induction of apoptosis by quercetin:
involvement of heat shock protein. Cancer Res. 54:4952–4957.
1994.PubMed/NCBI
|
|
23
|
Gorczyca W, Gong J, Ardelt B, Traganos F
and Darzynkiewicz Z: The cell cycle related differences in
susceptibility of HL-60 cells to apoptosis induced by various
antitumor agents. Cancer Res. 53:3186–3192. 1993.PubMed/NCBI
|
|
24
|
Barry MA, Reynolds JE and Eastman A:
Etoposide-induced apoptosis in human HL-60 cells is associated with
intracellular acidification. Cancer Res. 53:2349–2357.
1993.PubMed/NCBI
|
|
25
|
Sauter BV, Martinet O, Zhang WJ, Mandeli J
and Woo SL: Adenovirus-mediated gene transfer of endostatin in vivo
results in high level of transgene expression and inhibition of
tumor growth and metastases. Proc Natl Acad Sci USA. 97:4802–4807.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei YQ, Hang ZB and Liu KF: In situ
observation of inflammatory cell-tumor cell interaction in human
seminomas (germinomas): light, electron microscopic, and
immunohistochemical study. Hum Pathol. 23:421–428. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li G, Tian L, Hou JM, Ding ZY, He QM, Feng
P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Y, Luo F, Zhao X,
Zhang L, Zhou Q and Wei YQ: Improved therapeutic effectiveness by
combining recombinant CXC chemokine ligand 10 with cisplatin in
solid tumors. Clin Cancer Res. 11:4217–4224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao F, Wei Y, Yang L, Zhao X, Tian L,
Ding Z, Yuan S, Lou Y, Liu F, Wen Y, Li J, Deng H, Kang B, Mao Y,
Lei S, He Q, Su J, Lu Y, Niu T, Hou J and Huang MJ: A gene therapy
for cancer based on the angiogenesis inhibitor, vasostatin. Gene
Ther. 9:1207–1213. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peto R and Peto J: Asymptotically
efficient rank invariant test procedures. J R Stat Soc Ser A.
135:185–207. 1972. View
Article : Google Scholar
|
|
30
|
Malaguarnera L: Implications of apoptosis
regulators in tumorigenesis. Cancer Metastasis Rev. 23:367–387.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu TC and Kim D: Systemic efficacy with
oncolytic virus therapeutics: clinical proof-of-concept and future
directions. Cancer Res. 67:429–432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Parato KA, Senger D, Forsyth PA and Bell
JC: Recent progress in the battle between oncolytic viruses and
tumours. Nat Rev Cancer. 5:965–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
